Articles with "auto hsct" as a keyword



Photo by timmossholder from unsplash

Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial

Sign Up to like & get
recommendations!
Published in 2023 at "American Journal of Hematology"

DOI: 10.1002/ajh.26800

Abstract: We report a randomized prospective phase 3 study, designed to evaluate the efficacy and tolerability of idarubicin plus busulfan and cyclophosphamide (IDA‐BuCy) versus BuCy in autologous hematopoietic stem‐cell transplantation (auto‐HSCT) for intermediate‐risk acute myeloid leukemia… read more here.

Keywords: ida bucy; bucy; auto hsct;
Photo by timmossholder from unsplash

Induction with MEDA regimen and consolidation with Auto‐HSCT for stage IV NKTCL patients: A prospective multicenter study

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Cancer"

DOI: 10.1002/ijc.34055

Abstract: Optimal treatment strategies for natural killer/T‐cell lymphoma (NKTCL) patients with stage IV disease have not been well defined. In this prospective phase 2 study, we evaluated the treatment using MEDA (methotrexate, etoposide, dexamethasone and pegaspargase)… read more here.

Keywords: auto; auto hsct; nktcl patients; rate ... See more keywords
Photo from wikipedia

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZVIN) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients

Sign Up to like & get
recommendations!
Published in 2017 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofx162.141

Abstract: Abstract Background Recipients of auto-HSCT have an increased risk of herpes zoster (HZ) infection; however, live attenuated varicella-zoster virus (VZV) vaccine is contraindicated in these patients. In this pivotal Phase III study (V212-001; NCT01229267) inactivated… read more here.

Keywords: merck; vaccine; auto hsct; placebo ... See more keywords
Photo by aaronburden from unsplash

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China

Sign Up to like & get
recommendations!
Published in 2021 at "Chinese Medical Journal"

DOI: 10.1097/cm9.0000000000001575

Abstract: Supplemental Digital Content is available in the text Abstract Background: There were few studies on real-world data about autologous hematopoietic stem cell transplantation (auto-HSCT) or allogeneic HSCT (allo-HSCT) in peripheral T-cell lymphoma (PTCL). This study… read more here.

Keywords: allo hsct; study; auto hsct; cell ... See more keywords
Photo from wikipedia

The impact of pulmonary function in patients undergoing autologous stem cell transplantation.

Sign Up to like & get
recommendations!
Published in 2021 at "Blood advances"

DOI: 10.1182/bloodadvances.2021004863

Abstract: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is an established therapy for patients with hematological malignancies. The age of patients undergoing auto-HSCT, and therefore the co-morbidities, has increased during the last decades.… read more here.

Keywords: high dose; dose melphalan; auto hsct; patients undergoing ... See more keywords
Photo by miteneva from unsplash

Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis.

Sign Up to like & get
recommendations!
Published in 2023 at "Blood advances"

DOI: 10.1182/bloodadvances.2022009138

Abstract: The overall survival (OS) has improved significantly in multiple myeloma (MM) over the last decade with use of proteasome inhibitor and immunomodulatory drug-based combinations, followed by high-dose melphalan and autologous hematopoietic stem cell transplantation (auto-HSCT)… read more here.

Keywords: multiple myeloma; spm shm; second primary; auto hsct ... See more keywords
Photo by timmossholder from unsplash

Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients

Sign Up to like & get
recommendations!
Published in 2018 at "Oncotarget"

DOI: 10.18632/oncotarget.25553

Abstract: We investigated dynamics of CD4+FOXP3+ T cell recovery following the high-dose chemotherapy (HDC) with autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients. Circulating CD4+FOXP3+ T cells of 79 MM patients were evaluated… read more here.

Keywords: auto hsct; cd4 foxp3; circulating cd4; foxp3 cells ... See more keywords
Photo from wikipedia

Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.

Sign Up to like & get
recommendations!
Published in 2023 at "Internal medicine"

DOI: 10.2169/internalmedicine.1314-22

Abstract: Objective High-dose chemotherapy with autologous hematopoietic stem cell transplantation (auto-HSCT) is an effective treatment option for relapsed and refractory aggressive malignant lymphoma. However, patients frequently experience treatment-induced gastrointestinal symptoms. Synbiotics, including live microorganisms and nondigestible… read more here.

Keywords: patients undergoing; auto hsct; placebo; group ... See more keywords
Photo by artlasovsky from unsplash

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.1041177

Abstract: Background We aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). Research design and… read more here.

Keywords: car; cell; cell therapy; auto hsct ... See more keywords
Photo by nci from unsplash

Autologous hematopoietic stem cell transplantation for acute myeloid leukemia - single center experience.

Sign Up to like & get
recommendations!
Published in 2017 at "Neoplasma"

DOI: 10.4149/neo_2017_512

Abstract: We aimed to determine the effect of autologous hematopoietic stem cell transplantation (auto-HSCT) on acute myeloid leukemia (AML) patients as a valid alternative therapeutic option for patients without HLA-compatible donor. This retrospective single center study… read more here.

Keywords: auto; auto hsct; cell transplantation; autologous hematopoietic ... See more keywords